 |
| |
 | | Screening | |
- Determine BMI and waist circumference in all patients.
- Determine waist circumference in all patients as a second component in assessing health risk from obesity.
- Assess other factors that can influence interpretation of the BMI and waist circumference, such as rate of increase in body weight, ethnic group, age, gender, and level of physical activity.
|
|
Determine BMI and waist circumference in all patients.  |
- Measure weight and height and determine BMI: Wt(kg)/Ht(m2 ).
- See figure Body Mass Index.
| Background | Back to top
|
Determine waist circumference in all patients as a second component in assessing health risk from obesity.  |
| Background | Back to top
|
Assess other factors that can influence interpretation of the BMI and waist circumference, such as rate of increase in body weight, ethnic group, age, gender, and level of physical activity. |
- Determine annual rate of weight gain and identify patients who gain >1 kg (2 pounds) per year as high risk for comorbidities.
| Background | Back to top
| | | FAQs |
|
| George A. Bray, MD, is a speaker for Eli Lilly, Amylin Corp., and Merck & Co., received grants from Merck & Co., and Takeda Pharmaceuticals; and has consulted for Sanofi-Aventis, Merck, and Amylin.
Steven E. Weinberger, MD, FACP, Acting Editor, PIER, has stock holdings in Glaxosmithkline and Abbott. |
|
|
|
The information included herein should never be used as a substitute
for clinical judgment and does not represent an official position of
ACP. Because all PIER modules are updated regularly, printed web pages
or PDFs may rapidly become obsolete. Therefore, PIER users should
compare the date of the last update on the website with any printout
to ensure that the information being referred to is the most current
available.
|
PIER is copyrighted (c) 2009 by the American College of Physicians,
190 N. Independence Mall West, Philadelphia, PA 19106-1572, USA.
|
|
|
Obesity
